Psychedelic Therapies at a Turning Point: How Recent Federal Actions May Reshape Psychiatric Care

Steering Committee members Charles Raison, MD, and Andrew Penn, MS, PMHNP-BC, discuss why recent regulatory actions could mark an inflection point for psychedelic psychiatry.